DEPLOYDatabase

Company

Butterfly Network

Butterfly Network develops AI-powered handheld ultrasound technology, including the Butterfly iQ+ and Butterfly iQ3 probes that enable whole-body imaging from…

Founded
2011
HQ
Burlington, MA, USA
Status
public (NASDAQ: BFLY)

The verified answer

As of Aug 2026, DEPLOY verifies Butterfly Network: 2 models, 3 deployments across 3 regions, $1.0B raised, 2 active incidents. 1 source back the record.

Regulatory status1 FDA 510(k) clearance

Butterfly Network holds 1 FDA 510(k) clearance, per the DEPLOY registry.

See all 1 filings

CategoryBiometric wearables

Overview

Butterfly Network develops AI-powered handheld ultrasound technology, including the Butterfly iQ+ and Butterfly iQ3 probes that enable whole-body imaging from a single semiconductor-based device. Founded in 2011 by Dr. Jonathan Rothberg, the company went public via a $1.5B SPAC merger with Longview Acquisition Corp. in February 2021 and trades on NYSE under BFLY. The company has received multiple FDA clearances for AI-powered ultrasound tools and deploys across health systems including Atrium Health and Hennepin EMS.

Verified record

Verified deployments
3 deployments on file
Active incidents
2 incidents on file

Key facts

Revenue 2025

97.6M USD (company-reported)

Technology

Ultrasound-on-Chip semiconductor

SPAC merger date

2021-02-16 (Longview Acquisition Corp, $1.5B valuation)

Data & sources

News coverage

1

1 source backing this record.View all →

Butterfly Network on the deployment map

View the global map

3 verified deployments across 3 regions, newest verified Jan 2023. Explore where Butterfly Network's robots are operating, by place and type.

Free to use on your site, with a link back to DEPLOY.

View the full Butterfly Network deployment record →

Free to use on your site, with a link back to DEPLOY.

Relationships

Explainers

Plain-language answers to the questions people ask about Butterfly Network, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.

What is the Butterfly iQ+?
The Butterfly iQ+ is a handheld, single-probe whole-body ultrasound made by Butterfly Network. It uses the company's patented Ultrasound-on-Chip semiconductor instead of traditional crystals, connects to a smartphone, and is FDA-cleared for 13 clinical uses including cardiac, lung, abdominal, vascular, and obstetric imaging.Read the full explainer →
How much does the Butterfly iQ+ cost?
DEPLOY does not have a verified price for the Butterfly iQ+ on record. Butterfly Network sells it directly to clinicians and health systems rather than at a fixed public retail sticker, so treat any specific figure you see quoted as unverified until it is sourced to Butterfly.Read the full explainer →

Current leadership (4)

Founders (3)

See all founders across the registry →

Safety record

1 recall and 1 incident on record (1 moderate, 1 minor). Most recent: Mar 2026.

moderate
1
minor
1
regulatory action
1
recall
1

Most recent: Mar 2026

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Incidents affecting Butterfly Network (2)

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Operator customers (1)

Recent coverage

Butterfly Network in third-party press

Peer companies